Reports for APO-RIVASTIGMINE
Brand name
APO-RIVASTIGMINE
Company Name
APOTEX INC
|
Drug Identification Number
02336723 |
Ingredients
RIVASTIGMINE |
Ingredient Strength
3 MG |
ATC Code
N06DA |
ATC Descriptor
ANTI-DEMENTIA DRUGS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2019-06-12 | 2019-10-07 | 86336 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2021-07-05 | 2021-12-03 | 141854 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2023-09-28 | 2024-01-05 | 205501 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-RIVASTIGMINE | 100 BTL | Actual shortage | 2024-11-29 | 2024-11-29 | 244209 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0